Senti Biosciences

📍 South San Francisco, United States🗓 Founded 2016👥 53 employees💰 Last funded May 2020
Biotechnology Research🌐 sentibio.com
Website LinkedIn
Our mission is to create a new generation of smarter medicines that outmaneuver complex diseases in ways previously inconceivable. To accomplish this mission, we are building a synthetic biology platform that could enable us to program next-generation cell and gene therapies with what we refer to as “gene circuits”. These gene circuits, which are created from novel and proprietary combinations of DNA sequences, are intended to reprogram cells with biological logic to sense inputs, compute decisions and respond to their cellular environments. We are designing gene circuits to improve the “intelligence” of cell and gene therapies in order to enhance their therapeutic effectiveness against a broad range of diseases that conventional medicines do not readily address. For more information, please visit the Senti Bio website at https://www.sentibio.com.
3
Total investors
2
Early stage
1
Mid stage
0
Late stage
2016
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
3
Investor activity2017–2020 · investors recorded per year
201712018120201
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Senti Biosciences?
Senti Biosciences has 3 investors on record on gritt.io, including 2 early-stage backers, 1 mid-stage.
When did Senti Biosciences last raise funding?
The most recent investment in Senti Biosciences recorded on gritt.io was in May 2020.
When was Senti Biosciences founded?
Senti Biosciences was founded in 2016.
What industry is Senti Biosciences in?
Senti Biosciences operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Senti Biosciences based?
Senti Biosciences is headquartered in South San Francisco, United States.